Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the <scp>Canadian Registry</scp> for <scp>Pulmonary Fibrosis</scp>-Reference-Cited by-同舟云学术

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis

Published:2022-05-05 Issue:8 Volume:27 Page:635-644
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Lee Cathryn T.¹^ORCID,Strek Mary E.¹^ORCID,Adegunsoye Ayodeji¹^ORCID,Wong Alyson W.²³,Assayag Deborah⁴,Cox Gerard⁵,Fell Charlene D.⁶,Fisher Jolene H.⁷^ORCID,Gershon Andrea S.⁷^ORCID,Halayko Andrew J.⁸,Hambly Nathan⁵,Khalil Nasreen⁹,Kolb Martin⁵^ORCID,Lok Stacey D.¹⁰,Manganas Hélène¹¹,Marcoux Veronica¹⁰,Morisset Julie¹¹,Sadatsafavi Mohsen¹²,Shapera Shane⁷,To Teresa¹³,Wilcox Pearce²,Ryerson Christopher J.²³^ORCID,Johannson Kerri A.⁶^ORCID

Affiliation:

1. Pulmonary and Critical Care Medicine University of Chicago Chicago Illinois USA

2. Department of Medicine University of British Columbia Vancouver British Columbia Canada

3. Center for Heart Lung Innovation St. Paul's Hospital Vancouver British Columbia Canada

4. Department of Medicine McGill University Montreal Quebec Canada

5. Medicine (Respirology) McMaster University Hamilton Ontario Canada

6. Department of Medicine University of Calgary Calgary Alberta Canada

7. Department of Medicine University of Toronto Toronto Ontario Canada

8. Physiology/Internal Medicine (Respirology) University of Manitoba Winnipeg Manitoba Canada

9. Division of Respiratory Medicine University of British Columbia Vancouver British Columbia Canada

10. Department of Medicine University of Saskatchewan Saskatoon Saskatchewan Canada

11. Département de Médecine Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada

12. Faculty of Pharmaceutical Sciences The University of British Columbia Vancouver British Columbia Canada

13. Research Institute Hospital for Sick Children Toronto Ontario Canada

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/resp.14267

Reference17 articles.

1. Spectrum of Fibrotic Lung Diseases

2. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

3. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

4. The ageing lung under stress

5. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does a Type of Inciting Antigen Correlate with the Presence of Lung Fibrosis in Patients with Hypersensitivity Pneumonitis?;Journal of Clinical Medicine;2024-08-27

2. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-08-15

3. Organic Exposures, Radiologic Features, and Patterns in Fibrotic Interstitial Lung Disease;Annals of the American Thoracic Society;2024-08

4. Hypersensitivity Pneumonitis: A Silent Epidemic?;Current Pulmonology Reports;2024-05-25

5. The Impact of Occupational Exposures on the Risk of Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis;Annals of the American Thoracic Society;2023-12-14